These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 12174940

  • 1. Prognostic value of plasma vascular endothelial growth factor in patients with colorectal cancer.
    Nakayama Y, Sako T, Shibao K, Okazaki K, Rempo N, Onitsuka K, Minagawa N, Akahane K, Nagashima N, Nagata N, Itoh H.
    Anticancer Res; 2002; 22(4):2437-42. PubMed ID: 12174940
    [Abstract] [Full Text] [Related]

  • 2. Relationship between plasma levels of vascular endothelial growth factor and serum levels of interleukin-12 in patients with colorectal cancer.
    Nakayama Y, Sako T, Shibao K, Onitsuka K, Nagashima N, Hirata K, Nagata N, Itoh H.
    Anticancer Res; 2000; 20(6A):4097-102. PubMed ID: 11131678
    [Abstract] [Full Text] [Related]

  • 3. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group.
    Werther K, Christensen IJ, Brünner N, Nielsen HJ.
    Eur J Surg Oncol; 2000 Nov; 26(7):657-62. PubMed ID: 11078612
    [Abstract] [Full Text] [Related]

  • 4. Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer.
    Chin KF, Greenman J, Gardiner E, Kumar H, Topping K, Monson J.
    Br J Cancer; 2000 Dec; 83(11):1425-31. PubMed ID: 11076648
    [Abstract] [Full Text] [Related]

  • 5. Correlation of plasma level and immunohistochemical expression of vascular endothelial growth factor in patients with advanced colorectal cancer.
    Minagawa N, Nakayama Y, Hirata K, Onitsuka K, Inoue Y, Nagata N, Itoh H.
    Anticancer Res; 2002 Dec; 22(5):2957-63. PubMed ID: 12530025
    [Abstract] [Full Text] [Related]

  • 6. Vascular endothelial growth factor (VEGF)--a valuable serum tumour marker in patients with colorectal cancer?
    Broll R, Erdmann H, Duchrow M, Oevermann E, Schwandner O, Markert U, Bruch HP, Windhövel U.
    Eur J Surg Oncol; 2001 Feb; 27(1):37-42. PubMed ID: 11237490
    [Abstract] [Full Text] [Related]

  • 7. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?
    George ML, Eccles SA, Tutton MG, Abulafi AM, Swift RI.
    Clin Cancer Res; 2000 Aug; 6(8):3147-52. PubMed ID: 10955796
    [Abstract] [Full Text] [Related]

  • 8. Effects of IL-2 preoperative immunotherapy on surgery-induced changes in angiogenic regulation and its prevention of VEGF increase and IL-12 decline.
    Brivio F, Lissoni P, Rovelli F, Nespoli A, Uggeri F, Fumagalli L, Gardani G.
    Hepatogastroenterology; 2002 Aug; 49(44):385-7. PubMed ID: 11995457
    [Abstract] [Full Text] [Related]

  • 9. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
    Miyazaki T, Okada N, Ishibashi K, Ogata K, Ohsawa T, Ishiguro T, Nakada H, Yokoyama M, Matsuki M, Kato H, Kuwano H, Ishida H.
    Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
    [Abstract] [Full Text] [Related]

  • 10. Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival.
    Chen CA, Cheng WF, Lee CN, Chen TM, Kung CC, Hsieh FJ, Hsieh CY.
    Gynecol Oncol; 1999 Aug; 74(2):235-40. PubMed ID: 10419737
    [Abstract] [Full Text] [Related]

  • 11. Plasma vascular endothelial growth factor is useful in assessing progression of breast cancer post surgery and during adjuvant treatment.
    Wu Y, Saldana L, Chillar R, Vadgama JV.
    Int J Oncol; 2002 Mar; 20(3):509-16. PubMed ID: 11836562
    [Abstract] [Full Text] [Related]

  • 12. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
    Shang ZJ, Li JR, Li ZB.
    Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564
    [Abstract] [Full Text] [Related]

  • 13. Circulating vascular endothelial growth factor in patients with colorectal cancer.
    Fujisaki K, Mitsuyama K, Toyonaga A, Matsuo K, Tanikawa K.
    Am J Gastroenterol; 1998 Feb; 93(2):249-52. PubMed ID: 9468253
    [Abstract] [Full Text] [Related]

  • 14. Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma.
    Werther K, Christensen IJ, Nielsen HJ, Danish RANX05 Colorectal Cancer Study Group.
    Br J Cancer; 2002 Feb 01; 86(3):417-23. PubMed ID: 11875709
    [Abstract] [Full Text] [Related]

  • 15. Clinical significance of serum vascular endothelial growth factor in colorectal cancer patients: correlation with clinicopathological factors and tumor markers.
    Takeda A, Shimada H, Imaseki H, Okazumi S, Natsume T, Suzuki T, Ochiai T.
    Oncol Rep; 2000 Feb 01; 7(2):333-8. PubMed ID: 10671682
    [Abstract] [Full Text] [Related]

  • 16. Kinetics of postoperative serum vascular endothelial growth factor (VEGF)--can it be used to predict curative resections in colorectal cancer?
    Kumar H, Heer K, Duthie GS, Monson JR.
    Anticancer Res; 2002 Feb 01; 22(6B):3717-22. PubMed ID: 12552982
    [Abstract] [Full Text] [Related]

  • 17. Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1.
    Lissoni P, Malugani F, Bonfanti A, Bucovec R, Secondino S, Brivio F, Ferrari-Bravo A, Ferrante R, Vigoré L, Rovelli F, Mandalà M, Viviani S, Fumagalli L, Gardani GS.
    J Biol Regul Homeost Agents; 2001 Feb 01; 15(2):140-4. PubMed ID: 11501971
    [Abstract] [Full Text] [Related]

  • 18. Anti-angiogenic activity of melatonin in advanced cancer patients.
    Lissoni P, Rovelli F, Malugani F, Bucovec R, Conti A, Maestroni GJ.
    Neuro Endocrinol Lett; 2001 Feb 01; 22(1):45-7. PubMed ID: 11335879
    [Abstract] [Full Text] [Related]

  • 19. Prognostic relevance of serum vascular endothelial growth factor in ovarian cancer.
    Oehler MK, Caffier H.
    Anticancer Res; 2000 Feb 01; 20(6D):5109-12. PubMed ID: 11326678
    [Abstract] [Full Text] [Related]

  • 20. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
    Peng XP, Li JD, Li MD, Ye XM, Yan WC.
    Ai Zheng; 2002 Feb 01; 21(2):181-5. PubMed ID: 12479072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.